Recent Publications
To see a list of all publications http://www.ncbi.nlm.nih.gov/myncbi/1lqPkMgIJHhQc/bibliography/47848295/public/?sort=date&direction=ascending
Find Dr. Herbst-Kralovetz on ResearchGate: https://www.researchgate.net/profile/Melissa_Herbst-Kralovetz
Find Dr. Herbst-Kralovetz on ResearchGate: https://www.researchgate.net/profile/Melissa_Herbst-Kralovetz
Current and past Herbst-Kralovetz lab trainees are underlined in the publications below.
2024
Mancilla V, Jimenez NR, Bishop NS, Flores M, Herbst-Kralovetz MM. The Vaginal Microbiota, Human Papillomavirus Infection, and Cervical Carcinogenesis: A Systematic Review in the Latina Population. J Epidemiol Glob Health (2024). https://doi.org/10.1007/s44197-024-00201-z
2023
Chase DM, McCann LD, Treuth A, Cui H, Laniewski P, Jimenez NR, Mahnert ND, Roe DJ, Herbst-Kralovetz MM. Preoperative quality of life (QOL) at time of gynecologic surgery: considerations for postoperative management. AJOG global reports. 2023 Oct 14:100275. doi: 10.1016/j.xagr.2023.100275.
Elnaggar JH, Ardizzone CM, Cerca N, Toh E, Łaniewski P, Lillis RA, Herbst-Kralovetz MM, Quayle AJ, Muzny CA, Taylor CM. A novel Gardnerella, Prevotella, and Lactobacillus standard that improves accuracy in quantifying bacterial burden in vaginal microbial communities. Frontiers in Cellular and Infection Microbiology. 2023 Jun 19;13:1198113. doi: 10.3389/fcimb.2023.1198113. PMID: 37404722
Farland LV, Khan SM, Shilen A, Heslin KM, Ishimwe P, Allen AM, Herbst-Kralovetz MM, Mahnert ND, Pogreba-Brown K, Ernst KC and Jacobs ET. COVID-19 vaccination and changes in the menstrual cycle among vaccinated persons. Fertility and Sterility. 2023 Mar 1. 119(3), pp.392-400. doi: 10.1016/j.fertnstert.2022.12.023. PMID: 36539055
Jimenez NR, Maarsingh JD, Laniewski P, Herbst-Kralovetz MM. Commensal lactobacilli metabolically contribute to cervical epithelial homeostasis in a species-specific manner. mSphere. 2023 Jan 11:e0045222. doi: 10.1128/msphere.00452-22. PMID: 36629413.
2022
Laniewski P, Cui H, Mahnert ND, Mourad J, Borst MP, Willmott L, Chase DM, Roe DJ, Herbst-Kralovetz MM. Protein biomarkers in cervicovaginal lavages for detection of endometrial cancer. Biomark Res. 2022 Dec 2;10(1):88. doi: 10.1186/s40364-022-00438-5. PMID: 36461062.
Lorentzen GM, Laniewski P, Cui H, Roe DJ, Mourad J, Mahnert ND, Farland LV, Herbst-Kralovetz MM. Immunometabolic profiling of cervicovaginal lavages identifies key signatures associated with adenomyosis. iScience. 2022 Nov 4;25(12):105508. doi: 10.1016/j.isci.2022.105508. PMID: 36419846.
Morales CG, Jimenez NR, Herbst-Kralovetz MM, Lee NR. Novel vaccine strategies and factors to consider in addressing health disparities of HPV infection and cervical cancer development among Native American women. Med Sci (Basel). 2022 Sep 13;10(3):52. doi: 10.3390/medsci10030052. PMID: 36135837.
Maarsingh JD, Laniewski P, Herbst-Kralovetz MM. Immunometabolic and potential tumor-promoting changes in 3D cervical cell models infected with bacterial vaginosis-associated bacteria. Commun Biol. 2022 Jul 22;5(1):725. PMID: 35869172.
Kaelin EA, Skidmore PT, Laniewski P, Holland LA, Chase DM, Herbst-Kralovetz MM, Lim ES. Cervicovaginal DNA virome alterations are associated with genital inflammation and microbiota composition. mSystems. 2022; e0006422. PMID: 35343798.
Laniewski P, Herbst-Kralovetz MM. Connecting microbiome and menopause for healthy ageing. Nat Microbiol. 2022; 7(3):354-358. PMID: 35246661.
Bokulich NA*, Laniewski P*, Adamov A, Chase DM, Caporaso JG, Herbst-Kralovetz MM. Multi-omics data integration reveals metabolome as the top predictor of the cervicovaginal microenvironment. PLoS Comput Biol. 2022; 18(2):e1009876. PMID: 35196323. * These authors contributed equally
2021
McKenzie R, Maarsingh JD, Laniewski P, Herbst-Kralovetz MM. Immunometabolic analysis of Mobiluncus mulieris and Eggerthella sp. reveals novel insights into their pathogenic contributions to the hallmarks of bacterial vaginosis. Front Cell Infect Microbiol. 2021. 11:759697. PMID: 35004344
Laniewski P, Herbst-Kralovetz MM. Bacterial vaginosis and health-associated bacteria modulate the immunometabolic landscape in 3D model of human cervix. NPJ Biofilms Microbiomes. 2021. 7(1):88. PMID: 34903740
Salliss ME, Farland LV, Mahnert ND, Herbst-Kralovetz MM. The role of gut and genital microbiota and the estrobolome in endometriosis, infertility and chronic pelvic pain. Hum Reprod Update. 2021. 28(1):92-131. PMID: 34718567
Bordeaux SJ, Baca AW, Begay RL, Gachupin FC, Caporaso JG, Herbst-Kralovetz MM, Lee, NR. Designing inclusive HPV cancer vaccines and increasing uptake among Native Americans—a cultural perspective review. Curr Oncol. 2021. 28(5):3705-3716. PMID: 34590604
Salliss ME, Maarsingh JD, Garza C, Laniewski P, Herbst-Kralovetz MM. Veillonellaceae family members uniquely alter the cervicovaginal metabolic microenvironment in a human three-dimensional epithelial model. NPJ Biofilms Microbiomes. 2021. 7(1):57. PMID: 34230496
Laniewski P, Owen KA, Khnanisho M, Brotman RM, Herbst-Kralovetz MM. Clinical and personal lubricants impact growth of vaginal Lactobacillus species and colonization of vaginal epithelial cells: an in vitro study. Sex Transm Dis. 2021. 48(1):63-70. PMID: 32842049
2020
Jackson R, Maarsingh JD, Herbst-Kralovetz MM, Van Doorslaer K. 3D oral and cervical tissue models for studying papillomavirus host-pathogen interactions. Curr Protoc Microbiol. 2020. PMID: 33232584
Laniewski P, Cui H, Roe DJ, Chase DM, Herbst-Kralovetz MM. Vaginal microbiota, genital inflammation, and neoplasia impact immune checkpoint protein profiles in the cervicovaginal microenvironment. NPJ Precis Oncol. 2020. PMID: 32802959
Ilhan ZE, Laniewski P, Tonachio A, Herbst-Kralovetz MM. Members of Prevotella genus distinctively modulate innate immune and barrier functions in a human three-dimensional endometrial epithelial cell model. J Infect Dis. 2020. PMID: 32515473
Laniewski P, Ilhan ZE, Herbst-Kralovetz MM. The microbiome and gynaecological cancer development, prevention and therapy. Nat Rev Urol. 2020. PMID: 32071434
Muzny CA, Laniewski P, Schwebke JR, Herbst-Kralovetz MM. Host-vaginal microbiota interactions in the pathogenesis of bacterial vaginosis. Curr Opin Infect Dis. 2020. PMID: 31789672
Gardner JK, Laniewski P, Knight A, Haddad LB, Swaims-Kohlmeier A, Herbst-Kralovetz MM. IL-36gamma is elevated in cervicovaginal epithelial cells in women with bacterial vaginosis and in vitro after infection with microbes associated with bacterial vaginosis. J Infect Dis. 2020. PMID: 31586390
2019
Gardner JK, Swaims-Kohlmeier A, Herbst-Kralovetz MM. IL-36gamma is a key regulator of neutrophil infiltration in the vaginal microenvironment and limits neuroinvasion in genital HSV-2 infection. J. Immunol. 2019. PMID: 30118914
Wilkinson EM, Laniewski P, Herbst-Kralovetz MM, Brotman RM. Personal and clinical vaginal lubricants: Impact on local vaginal microenvironment and implications for epithelial cell host response and barrier function. J Infect Dis. 2019. PMID: 31539059
Laniewski P, Herbst-Kralovetz MM. Analysis of Host Responses to Neisseria gonorrhoeae Using a Human Three-Dimensional Endometrial Epithelial Cell Model. Methods Mol Biol. 2019. PMID: 31119633
Swaims-Kohlmeier A, Haddad LB, Li ZRT, Brookmeyer KA, Baker JM, Widom CS, Lamousin JC, Chi KH, Chen CY, Kersh EN, Johnson JA, Herbst-Kralovetz MM, Hogben M, Ofotokun I, Kohlmeier JE. Chronic immune barrier dysregulation among women with a history of violence victimization. JCI Insight. 2019. PMID: 31092736
Laniewski P, Cui H, Roe DJ, Barnes D, Goulder A, Monk BJ, Greenspan DL, Chase DM, Herbst-Kralovetz MM. Features of the cervicovaginal microenvironment drive cancer biomarker signatures in patients across cervical carcinogenesis. Sci Rep. 2019. PMID: 31089160
Ilhan ZE, Laniewski P, Thomas N, Roe DJ, Chase DM, Herbst-Kralovetz MM. Deciphering the complex interplay between microbiota, HPV, inflammation and cancer through cervicovaginal metabolic profiling. EBioMedicine. 2019. PMID: 31027917
2018
Gardner JK, Herbst-Kralovetz MM. IL-36gamma induces a transient HSV-2 resistant environment that protects against genital disease and pathogenesis. Cytokine. 2018. PMID: 30118914
Laniewski P, Herbst-Kralovetz MM. Vagina. In: Skinner M (Ed). Encyclopedia of Reproduction. vol 2. 353-359. Academic Press: Elsevier. 2018. www.elsevier.com/books/encyclopedia-of-reproduction/skinner/978-0-12-811899-3
Laniewski P, Barnes D, Goulder A, Cui H, Roe DJ, Chase DM, Herbst-Kralovetz MM. Linking Cervicovaginal immune signatures, HPV and microbiota composition in cervical carcinogenesis in non-Hispanic and Hispanic women. Sci Rep. 2018. PMID: 29765068
Wilkinson EM, Ilhan ZE, Herbst-Kralovetz MM. Microbiota-Drug Interactions: Impact on Metabolism and Efficacy of Therapeutics. Maturitas. 2018. PMID: 29704918
Baker JM, Chase DM, Herbst-Kralovetz MM. Uterine Microbiota: Residents, Tourists, or Invaders? Front Immunol. 2018. PMID: 29552006
2017
Baker JM, Al-Nakkash L, Herbst-Kralovetz MM. Estrogen-gut microbiome axis: Physiological and clinical implications. Maturitas. 2017. PMID: 28778332
Laniewski P, Gomez A, Hire G, So M, Herbst-Kralovetz MM. Human three-dimensional endometrial epithelial cell model to study host interactions with vaginal bacterial and Neisseria gonorrhoeae. Infect Immun. 2017. PMID: 28052997
2016
Gardner JK, Herbst-Kralovetz MM. Three-dimensional rotating wall vessel-derived cell culture models for studying virus-host interactions. Viruses. 2016. PMID: 27834891
Herbst-Kralovetz MM, Pyles RB, Ratner AJ, Sycuro LK, Mitchell C. New systems for studying intercellular interactions in bacterial vaginosis. J Infect Dis. 2016. PMID: 27449872
Muhleisen A, Herbst-Kralovetz MM. Menopause and the vaginal microbiome. Maturitas. 2016 Sep. PMID: 27451320
Winkle S, Throop L, Herbst-Kralovetz MM. IL-36gamma augments host defense and immune responses in human female reproductive tract epithelial cells. Front Microbiol. 2016 Jun. PMID: 27379082
2015
Chase D, Goulder A, Zenhausern F, Monk B, Herbst-Kralovetz M. The vaginal and gastrointestinal microbiomes in gynecologic cancers: A review of applications in etiology, symptoms and treatment. Gynecol Oncol. 2015 Jul. PMID: 25957158
Yarbrough VL, Winkle S, Herbst-Kralovetz MM. Antimicrobial peptides in the female reproductive tract: a critical component of the mucosal immune barrier with physiological and clinical implications. Hum Reprod Update. 2015. PMID: 25547201
2014
Herbst-Kralovetz MM. Overcoming barriers in the mucosal delivery of virus-like particle-based vaccines. Ther Deliv. 2014 Jul. PMID: 25287380
*Mathew, LG, *Herbst-Kralovetz, MM and H. S. Mason. Norovirus Narita 104 Virus-Like Particles Expressed in Nicotiana benthamiana Induce Serum and Mucosal Immune Responses. BioMed Res Int. 2014. PMID: 24949472
Doerflinger SY, Throop AL, Herbst-Kralovetz MM. Bacteria in the Vaginal Microbiome Alter the Innate Immune Response and Barrier Properties of the Human Vaginal Epithelia in a Species-Specific Manner. J Infect Dis. 2014 Feb 12. PMID: 24403560
Hjelm BE, Kilbourne J, Herbst-Kralovetz MM. TLR7 and 9 agonists are highly effective mucosal adjuvants for norovirus virus-like particle vaccines. Hum Vaccin Immunother. 2014. PMID: 24280723
2013
McGowin CL, Radtke AL, Abraham K, Martin DH, Herbst-Kralovetz M. Mycoplasma genitalium infection activates cellular host defense and inflammation pathways in a 3-dimensional human endocervical epithelial cell model. J Infect Dis. 2013 Jun 15. PMID: 23493725
Herbst-Kralovetz MM, Radtke AL, Lay MK, Hjelm BE, Bolick AN, Sarker SS, Atmar RL, Kingsley DH, Arntzen CJ, Estes MK, Nickerson CA. Lack of Norovirus replication and histo-blood group antigen expression in 3-dimensional intestinal epithelial cells. Emerg Infec Dis. 2013 Mar. PMID: 23622517
2012
Radtke AL, Quayle AJ, Herbst-Kralovetz MM. Microbial products alter the expression of membrane-associated mucin and antimicrobial peptides in a three-dimensional human endocervical epithelial cell model. Biol Reprod. 2012 Dec. PMID: 23053434
Radtke AL, Herbst-Kralovetz MM. Culturing and application of rotating wall vessel bioreactor derived 3D epithelial cell models. J Vis Exp. 2012 Apr. PMID: 22491366
Jackson EM, Herbst-Kralovetz MM. Intranasal vaccination with murabutide enhances humoral and mucosal immune response to virus-like particle vaccine. PLoS One. 2012. PMID: 22855691
Mason HS, Herbst-Kralovetz MM. Plant derived antigens as mucosal vaccines. Curr Top Microbiol Immunol. 2012. PMID: 21811930
2011
Phoolcharoen W, Dye JM, Kilbourne J, Piensook K, Pratt WD, Arntzen CJ, Chen Q, Mason HS, Herbst-Kralovetz MM. A nonreplicating subunit vaccine protects mice against lethal Ebola challenge. Proc Natl Acad Sci USA. 2011 Dec. PMID: 22143779
Velasquez LS, Shira S, Berta AN, Kilbourne J, Medi BM, Tizard I, Ni Y, Arntzen CJ, Herbst-Kralovetz MM. Intranasal delivery or Norwalk virus-like particles formulated in an in-situ gelling, dry powder vaccine. Vaccine. 2011 Jun. PMID: 21640778
2010
Velasquez LS, Hjelm BE, Arntzen CJ, Herbst-Kralovetz MM. An intranasally delivered Toll-like receptor 7 agonist elicits robust systemic and mucosal responses to Norwalk virus-like particles. Clin Vaccine Immunol. 2010 Dec. PMID: 20962211
Barrila J, Radtke AL, Crabbé A, Sarker SF, Herbst-Kralovetz MM, Ott CM, Nickerson CA. Organotypic 3D cell culture models: using the rotating wall vessel to study host-pathogen interactions. Nat Rev Microbiol. 2010 Nov. PMID: 20948552
Hjelm BE, Berta AN, Nickerson CA, Arntzen CJ, Herbst-Kralovetz MM. Development and characterization of a three-dimensional organotypic human vaginal epithelial cell model. Biol Reprod. 2010 Mar. PMID: 20007410
Herbst-Kralovetz M, Mason HS, Chen Q. Norwalk virus-like particles as vaccines. Expert Rev Vaccines. 2010 Mar. PMID: 20218858
2024
Mancilla V, Jimenez NR, Bishop NS, Flores M, Herbst-Kralovetz MM. The Vaginal Microbiota, Human Papillomavirus Infection, and Cervical Carcinogenesis: A Systematic Review in the Latina Population. J Epidemiol Glob Health (2024). https://doi.org/10.1007/s44197-024-00201-z
2023
Chase DM, McCann LD, Treuth A, Cui H, Laniewski P, Jimenez NR, Mahnert ND, Roe DJ, Herbst-Kralovetz MM. Preoperative quality of life (QOL) at time of gynecologic surgery: considerations for postoperative management. AJOG global reports. 2023 Oct 14:100275. doi: 10.1016/j.xagr.2023.100275.
Elnaggar JH, Ardizzone CM, Cerca N, Toh E, Łaniewski P, Lillis RA, Herbst-Kralovetz MM, Quayle AJ, Muzny CA, Taylor CM. A novel Gardnerella, Prevotella, and Lactobacillus standard that improves accuracy in quantifying bacterial burden in vaginal microbial communities. Frontiers in Cellular and Infection Microbiology. 2023 Jun 19;13:1198113. doi: 10.3389/fcimb.2023.1198113. PMID: 37404722
Farland LV, Khan SM, Shilen A, Heslin KM, Ishimwe P, Allen AM, Herbst-Kralovetz MM, Mahnert ND, Pogreba-Brown K, Ernst KC and Jacobs ET. COVID-19 vaccination and changes in the menstrual cycle among vaccinated persons. Fertility and Sterility. 2023 Mar 1. 119(3), pp.392-400. doi: 10.1016/j.fertnstert.2022.12.023. PMID: 36539055
Jimenez NR, Maarsingh JD, Laniewski P, Herbst-Kralovetz MM. Commensal lactobacilli metabolically contribute to cervical epithelial homeostasis in a species-specific manner. mSphere. 2023 Jan 11:e0045222. doi: 10.1128/msphere.00452-22. PMID: 36629413.
2022
Laniewski P, Cui H, Mahnert ND, Mourad J, Borst MP, Willmott L, Chase DM, Roe DJ, Herbst-Kralovetz MM. Protein biomarkers in cervicovaginal lavages for detection of endometrial cancer. Biomark Res. 2022 Dec 2;10(1):88. doi: 10.1186/s40364-022-00438-5. PMID: 36461062.
Lorentzen GM, Laniewski P, Cui H, Roe DJ, Mourad J, Mahnert ND, Farland LV, Herbst-Kralovetz MM. Immunometabolic profiling of cervicovaginal lavages identifies key signatures associated with adenomyosis. iScience. 2022 Nov 4;25(12):105508. doi: 10.1016/j.isci.2022.105508. PMID: 36419846.
Morales CG, Jimenez NR, Herbst-Kralovetz MM, Lee NR. Novel vaccine strategies and factors to consider in addressing health disparities of HPV infection and cervical cancer development among Native American women. Med Sci (Basel). 2022 Sep 13;10(3):52. doi: 10.3390/medsci10030052. PMID: 36135837.
Maarsingh JD, Laniewski P, Herbst-Kralovetz MM. Immunometabolic and potential tumor-promoting changes in 3D cervical cell models infected with bacterial vaginosis-associated bacteria. Commun Biol. 2022 Jul 22;5(1):725. PMID: 35869172.
Kaelin EA, Skidmore PT, Laniewski P, Holland LA, Chase DM, Herbst-Kralovetz MM, Lim ES. Cervicovaginal DNA virome alterations are associated with genital inflammation and microbiota composition. mSystems. 2022; e0006422. PMID: 35343798.
Laniewski P, Herbst-Kralovetz MM. Connecting microbiome and menopause for healthy ageing. Nat Microbiol. 2022; 7(3):354-358. PMID: 35246661.
Bokulich NA*, Laniewski P*, Adamov A, Chase DM, Caporaso JG, Herbst-Kralovetz MM. Multi-omics data integration reveals metabolome as the top predictor of the cervicovaginal microenvironment. PLoS Comput Biol. 2022; 18(2):e1009876. PMID: 35196323. * These authors contributed equally
2021
McKenzie R, Maarsingh JD, Laniewski P, Herbst-Kralovetz MM. Immunometabolic analysis of Mobiluncus mulieris and Eggerthella sp. reveals novel insights into their pathogenic contributions to the hallmarks of bacterial vaginosis. Front Cell Infect Microbiol. 2021. 11:759697. PMID: 35004344
Laniewski P, Herbst-Kralovetz MM. Bacterial vaginosis and health-associated bacteria modulate the immunometabolic landscape in 3D model of human cervix. NPJ Biofilms Microbiomes. 2021. 7(1):88. PMID: 34903740
Salliss ME, Farland LV, Mahnert ND, Herbst-Kralovetz MM. The role of gut and genital microbiota and the estrobolome in endometriosis, infertility and chronic pelvic pain. Hum Reprod Update. 2021. 28(1):92-131. PMID: 34718567
Bordeaux SJ, Baca AW, Begay RL, Gachupin FC, Caporaso JG, Herbst-Kralovetz MM, Lee, NR. Designing inclusive HPV cancer vaccines and increasing uptake among Native Americans—a cultural perspective review. Curr Oncol. 2021. 28(5):3705-3716. PMID: 34590604
Salliss ME, Maarsingh JD, Garza C, Laniewski P, Herbst-Kralovetz MM. Veillonellaceae family members uniquely alter the cervicovaginal metabolic microenvironment in a human three-dimensional epithelial model. NPJ Biofilms Microbiomes. 2021. 7(1):57. PMID: 34230496
Laniewski P, Owen KA, Khnanisho M, Brotman RM, Herbst-Kralovetz MM. Clinical and personal lubricants impact growth of vaginal Lactobacillus species and colonization of vaginal epithelial cells: an in vitro study. Sex Transm Dis. 2021. 48(1):63-70. PMID: 32842049
2020
Jackson R, Maarsingh JD, Herbst-Kralovetz MM, Van Doorslaer K. 3D oral and cervical tissue models for studying papillomavirus host-pathogen interactions. Curr Protoc Microbiol. 2020. PMID: 33232584
Laniewski P, Cui H, Roe DJ, Chase DM, Herbst-Kralovetz MM. Vaginal microbiota, genital inflammation, and neoplasia impact immune checkpoint protein profiles in the cervicovaginal microenvironment. NPJ Precis Oncol. 2020. PMID: 32802959
Ilhan ZE, Laniewski P, Tonachio A, Herbst-Kralovetz MM. Members of Prevotella genus distinctively modulate innate immune and barrier functions in a human three-dimensional endometrial epithelial cell model. J Infect Dis. 2020. PMID: 32515473
Laniewski P, Ilhan ZE, Herbst-Kralovetz MM. The microbiome and gynaecological cancer development, prevention and therapy. Nat Rev Urol. 2020. PMID: 32071434
Muzny CA, Laniewski P, Schwebke JR, Herbst-Kralovetz MM. Host-vaginal microbiota interactions in the pathogenesis of bacterial vaginosis. Curr Opin Infect Dis. 2020. PMID: 31789672
Gardner JK, Laniewski P, Knight A, Haddad LB, Swaims-Kohlmeier A, Herbst-Kralovetz MM. IL-36gamma is elevated in cervicovaginal epithelial cells in women with bacterial vaginosis and in vitro after infection with microbes associated with bacterial vaginosis. J Infect Dis. 2020. PMID: 31586390
2019
Gardner JK, Swaims-Kohlmeier A, Herbst-Kralovetz MM. IL-36gamma is a key regulator of neutrophil infiltration in the vaginal microenvironment and limits neuroinvasion in genital HSV-2 infection. J. Immunol. 2019. PMID: 30118914
Wilkinson EM, Laniewski P, Herbst-Kralovetz MM, Brotman RM. Personal and clinical vaginal lubricants: Impact on local vaginal microenvironment and implications for epithelial cell host response and barrier function. J Infect Dis. 2019. PMID: 31539059
Laniewski P, Herbst-Kralovetz MM. Analysis of Host Responses to Neisseria gonorrhoeae Using a Human Three-Dimensional Endometrial Epithelial Cell Model. Methods Mol Biol. 2019. PMID: 31119633
Swaims-Kohlmeier A, Haddad LB, Li ZRT, Brookmeyer KA, Baker JM, Widom CS, Lamousin JC, Chi KH, Chen CY, Kersh EN, Johnson JA, Herbst-Kralovetz MM, Hogben M, Ofotokun I, Kohlmeier JE. Chronic immune barrier dysregulation among women with a history of violence victimization. JCI Insight. 2019. PMID: 31092736
Laniewski P, Cui H, Roe DJ, Barnes D, Goulder A, Monk BJ, Greenspan DL, Chase DM, Herbst-Kralovetz MM. Features of the cervicovaginal microenvironment drive cancer biomarker signatures in patients across cervical carcinogenesis. Sci Rep. 2019. PMID: 31089160
Ilhan ZE, Laniewski P, Thomas N, Roe DJ, Chase DM, Herbst-Kralovetz MM. Deciphering the complex interplay between microbiota, HPV, inflammation and cancer through cervicovaginal metabolic profiling. EBioMedicine. 2019. PMID: 31027917
2018
Gardner JK, Herbst-Kralovetz MM. IL-36gamma induces a transient HSV-2 resistant environment that protects against genital disease and pathogenesis. Cytokine. 2018. PMID: 30118914
Laniewski P, Herbst-Kralovetz MM. Vagina. In: Skinner M (Ed). Encyclopedia of Reproduction. vol 2. 353-359. Academic Press: Elsevier. 2018. www.elsevier.com/books/encyclopedia-of-reproduction/skinner/978-0-12-811899-3
Laniewski P, Barnes D, Goulder A, Cui H, Roe DJ, Chase DM, Herbst-Kralovetz MM. Linking Cervicovaginal immune signatures, HPV and microbiota composition in cervical carcinogenesis in non-Hispanic and Hispanic women. Sci Rep. 2018. PMID: 29765068
Wilkinson EM, Ilhan ZE, Herbst-Kralovetz MM. Microbiota-Drug Interactions: Impact on Metabolism and Efficacy of Therapeutics. Maturitas. 2018. PMID: 29704918
Baker JM, Chase DM, Herbst-Kralovetz MM. Uterine Microbiota: Residents, Tourists, or Invaders? Front Immunol. 2018. PMID: 29552006
2017
Baker JM, Al-Nakkash L, Herbst-Kralovetz MM. Estrogen-gut microbiome axis: Physiological and clinical implications. Maturitas. 2017. PMID: 28778332
Laniewski P, Gomez A, Hire G, So M, Herbst-Kralovetz MM. Human three-dimensional endometrial epithelial cell model to study host interactions with vaginal bacterial and Neisseria gonorrhoeae. Infect Immun. 2017. PMID: 28052997
2016
Gardner JK, Herbst-Kralovetz MM. Three-dimensional rotating wall vessel-derived cell culture models for studying virus-host interactions. Viruses. 2016. PMID: 27834891
Herbst-Kralovetz MM, Pyles RB, Ratner AJ, Sycuro LK, Mitchell C. New systems for studying intercellular interactions in bacterial vaginosis. J Infect Dis. 2016. PMID: 27449872
Muhleisen A, Herbst-Kralovetz MM. Menopause and the vaginal microbiome. Maturitas. 2016 Sep. PMID: 27451320
Winkle S, Throop L, Herbst-Kralovetz MM. IL-36gamma augments host defense and immune responses in human female reproductive tract epithelial cells. Front Microbiol. 2016 Jun. PMID: 27379082
2015
Chase D, Goulder A, Zenhausern F, Monk B, Herbst-Kralovetz M. The vaginal and gastrointestinal microbiomes in gynecologic cancers: A review of applications in etiology, symptoms and treatment. Gynecol Oncol. 2015 Jul. PMID: 25957158
Yarbrough VL, Winkle S, Herbst-Kralovetz MM. Antimicrobial peptides in the female reproductive tract: a critical component of the mucosal immune barrier with physiological and clinical implications. Hum Reprod Update. 2015. PMID: 25547201
2014
Herbst-Kralovetz MM. Overcoming barriers in the mucosal delivery of virus-like particle-based vaccines. Ther Deliv. 2014 Jul. PMID: 25287380
*Mathew, LG, *Herbst-Kralovetz, MM and H. S. Mason. Norovirus Narita 104 Virus-Like Particles Expressed in Nicotiana benthamiana Induce Serum and Mucosal Immune Responses. BioMed Res Int. 2014. PMID: 24949472
Doerflinger SY, Throop AL, Herbst-Kralovetz MM. Bacteria in the Vaginal Microbiome Alter the Innate Immune Response and Barrier Properties of the Human Vaginal Epithelia in a Species-Specific Manner. J Infect Dis. 2014 Feb 12. PMID: 24403560
Hjelm BE, Kilbourne J, Herbst-Kralovetz MM. TLR7 and 9 agonists are highly effective mucosal adjuvants for norovirus virus-like particle vaccines. Hum Vaccin Immunother. 2014. PMID: 24280723
2013
McGowin CL, Radtke AL, Abraham K, Martin DH, Herbst-Kralovetz M. Mycoplasma genitalium infection activates cellular host defense and inflammation pathways in a 3-dimensional human endocervical epithelial cell model. J Infect Dis. 2013 Jun 15. PMID: 23493725
Herbst-Kralovetz MM, Radtke AL, Lay MK, Hjelm BE, Bolick AN, Sarker SS, Atmar RL, Kingsley DH, Arntzen CJ, Estes MK, Nickerson CA. Lack of Norovirus replication and histo-blood group antigen expression in 3-dimensional intestinal epithelial cells. Emerg Infec Dis. 2013 Mar. PMID: 23622517
2012
Radtke AL, Quayle AJ, Herbst-Kralovetz MM. Microbial products alter the expression of membrane-associated mucin and antimicrobial peptides in a three-dimensional human endocervical epithelial cell model. Biol Reprod. 2012 Dec. PMID: 23053434
Radtke AL, Herbst-Kralovetz MM. Culturing and application of rotating wall vessel bioreactor derived 3D epithelial cell models. J Vis Exp. 2012 Apr. PMID: 22491366
Jackson EM, Herbst-Kralovetz MM. Intranasal vaccination with murabutide enhances humoral and mucosal immune response to virus-like particle vaccine. PLoS One. 2012. PMID: 22855691
Mason HS, Herbst-Kralovetz MM. Plant derived antigens as mucosal vaccines. Curr Top Microbiol Immunol. 2012. PMID: 21811930
2011
Phoolcharoen W, Dye JM, Kilbourne J, Piensook K, Pratt WD, Arntzen CJ, Chen Q, Mason HS, Herbst-Kralovetz MM. A nonreplicating subunit vaccine protects mice against lethal Ebola challenge. Proc Natl Acad Sci USA. 2011 Dec. PMID: 22143779
Velasquez LS, Shira S, Berta AN, Kilbourne J, Medi BM, Tizard I, Ni Y, Arntzen CJ, Herbst-Kralovetz MM. Intranasal delivery or Norwalk virus-like particles formulated in an in-situ gelling, dry powder vaccine. Vaccine. 2011 Jun. PMID: 21640778
2010
Velasquez LS, Hjelm BE, Arntzen CJ, Herbst-Kralovetz MM. An intranasally delivered Toll-like receptor 7 agonist elicits robust systemic and mucosal responses to Norwalk virus-like particles. Clin Vaccine Immunol. 2010 Dec. PMID: 20962211
Barrila J, Radtke AL, Crabbé A, Sarker SF, Herbst-Kralovetz MM, Ott CM, Nickerson CA. Organotypic 3D cell culture models: using the rotating wall vessel to study host-pathogen interactions. Nat Rev Microbiol. 2010 Nov. PMID: 20948552
Hjelm BE, Berta AN, Nickerson CA, Arntzen CJ, Herbst-Kralovetz MM. Development and characterization of a three-dimensional organotypic human vaginal epithelial cell model. Biol Reprod. 2010 Mar. PMID: 20007410
Herbst-Kralovetz M, Mason HS, Chen Q. Norwalk virus-like particles as vaccines. Expert Rev Vaccines. 2010 Mar. PMID: 20218858